From major journals, first or last author from the Institute for Cancer Research
Bergholtz H, Norum JH, Lien TG, Skrede ML, Garred Ø, Sørlie T(2025) B cells and energy metabolism in HER2-positive DCIS: insights into breast cancer progression from spatial-omics analyses Breast Cancer Res, 27(1), 44 DOI 10.1186/s13058-025-01990-2, PubMed 40119362
Tanoli Z, Fernández-Torras A, Özcan UO, Kushnir A, Nader KM, Gadiya Y, Fiorenza L, Ianevski A, Vähä-Koskela M, Miihkinen M, Seemab U, Leinonen H, Seashore-Ludlow B, Tampere M, Kalman A, Ballante F, Benfenati E, Saunders G, Potdar S, Gómez García I, García-Serna R, Talarico C, Beccari AR, Schaal W, Polo Aet al.(2025) Computational drug repurposing: approaches, evaluation of in silico resources and case studies Nat Rev Drug Discov(in press) DOI 10.1038/s41573-025-01164-x, PubMed 40102635
Skotland T, Ekroos K, Llorente A, Sandvig K(2025) Quantitative Lipid Analysis of Extracellular Vesicle Preparations: A Perspective J Extracell Vesicles, 14(3), e70049 DOI 10.1002/jev2.70049, PubMed 40091364
Blilie A, Giskeødegård GF, Nybøen Å, Krossa S, Midtbust E, Gudlaugsson E, Aasprong OG, Skogseth H, Halgunset J, Janssen EAM, Tessem MB, Taskén KA(2025) Biobanking after Radical Prostatectomy: Comparison of Slice and Punch Protocols Biopreserv Biobank(in press) DOI 10.1089/bio.2024.0175, PubMed 40206019
Kondo T, Bourassa FXP, Achar S, DuSold J, Céspedes PF, Ando M, Dwivedi A, Moraly J, Chien C, Majdoul S, Kenet AL, Wahlsten M, Kvalvaag A, Jenkins E, Kim SP, Ade CM, Yu Z, Gaud G, Davila M, Love P, Yang JC, Dustin ML, Altan-Bonnet G, François P, Taylor N(2025) Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificity Cell(in press) DOI 10.1016/j.cell.2025.03.017, PubMed 40220754
Nygrén P, Bouhlal J, Jokinen E, Forstén S, Laajala E, Dias D, Adnan-Awad S, Ianevski A, Klievink J, Lähteenmäki H, Kuusanmäki H, Myllymäki M, Kasanen T, Saeed K, Lee DA, Hjorth-Hansen H, Aittokallio T, Dufva O, Mustjoki S(2025) High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia Blood, 145(15), 1670-1686 DOI 10.1182/blood.2024025286, PubMed 39792962